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The therapeutic goal in bipolar disorder is to restore and
maintain mental health with few relapses. To date, the
efficacy of many mood stabilizer drugs has been assessed
in patients with bipolar disorder at different stage of their
disease. Mood stabilizers are defined as any medication
that stabilizes acute manic, mixed, and depressive symp-
toms and does not induce alternate mood symptoms, and
prevents against future relapses into manic, mixed, or
depressive symptoms or episodes. Mood stabilizers gener-
ally include lithium, antiepileptics, and atypical antipsy-
chotics. However medication tolerability and adherence
issues are often reasons why patients do not achieve favo-
rable outcomes. As such, clinicians need to systematically
assess and address all the barriers to therapy adherence, a
major risk factor for bipolar disorder management failure.
As with all drugs, many treatments are associated with
undesirable side effects. Patients with bipolar disorders
share with those with schizophrenia some adverse effects
including an increased risk for excessive weight gain, dia-
betes, and dyslipidemia (metabolic syndrome). Monitor-
ing of drug levels, lipids, blood glucose, metabolic
parameters, and weight is essential toward achieving the
desired efficacy and preserving quality of life. Patients
need to be educated as to the frequency of these side
effects. Moreover, the patient's perceptions about the rel-
ative risks and benefits of treatment are a strong determi-
nant of medication regimen adherence. The management
of bipolar disorder requires a carefully planned strategic
partnership between the patient, support systems, and all
health care providers.
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